IMA vs OXY
ImageneBio, Inc. (IMA) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
OXY (OXY) common stock.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
OXY does not have a complete income-statement cache yet.
IMA currently screens at market cap $64.7M. OXY currently screens at market cap $0.
Not investment advice. Open the IMA and OXY stock pages for the full models.
Not investment advice.